155 related articles for article (PubMed ID: 22421528)
1. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
[TBL] [Abstract][Full Text] [Related]
2. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
[TBL] [Abstract][Full Text] [Related]
4. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
[TBL] [Abstract][Full Text] [Related]
5. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
[TBL] [Abstract][Full Text] [Related]
6. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
[TBL] [Abstract][Full Text] [Related]
7. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
[TBL] [Abstract][Full Text] [Related]
9. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
Kim JM; Lyons D; Shin IS; Yoon JS
Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
[TBL] [Abstract][Full Text] [Related]
11. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
[TBL] [Abstract][Full Text] [Related]
12. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
[TBL] [Abstract][Full Text] [Related]
13. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
Hamuro A; Saito S
Psychogeriatrics; 2010 Dec; 10(4):198-200. PubMed ID: 21159055
[TBL] [Abstract][Full Text] [Related]
14. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
[TBL] [Abstract][Full Text] [Related]
15. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
Kung FC; Ishii R; Liu HC; Takeda M
Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
[TBL] [Abstract][Full Text] [Related]
16. Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies.
Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
J Am Geriatr Soc; 2011 May; 59(5):936-8. PubMed ID: 21568966
[No Abstract] [Full Text] [Related]
17. Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms.
Kimura T; Hayashida H; Furukawa H; Takamatsu J
Psychiatry Clin Neurosci; 2010 Apr; 64(2):207-10. PubMed ID: 20447015
[TBL] [Abstract][Full Text] [Related]
18. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
[TBL] [Abstract][Full Text] [Related]
19. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
20. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M
No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]